CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2
Liying Chen(Harbin University of Science and Technology), Kimberly Stegmaier(Broad Institute)
Cited by 159
Related Papers
Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting
|Cancer Discovery|2016|632
Gene expression–based high-throughput screening(GE-HTS) and application to leukemia differentiation
|Nature Genetics|2004|269
The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemia
|Journal of Clinical Investigation|2012|104